Predictions
TOP Ships Inc.
Start price
Target price
Perf. (%)
€20.80
14.12.20
14.12.20
€40.00
28.85%
11.01.21
11.01.21
Could be very worthwhile Investment >20% year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€13.00
14.12.20
14.12.20
€25.00
14.12.21
14.12.21
71.15%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
vTv Therapeutics Inc
Start price
Target price
Perf. (%)
€2.30
12.12.20
12.12.20
€1.00
12.12.21
12.12.21
-14.22%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
overvalued
Sonoma Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.90
12.12.20
12.12.20
€3.00
12.12.21
12.12.21
-8.48%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
Decining EBIT margin than peer group
EBIT decline > 20% expected
aTyr Pharma Inc
Start price
Target price
Perf. (%)
€3.78
12.12.20
12.12.20
€2.00
12.12.21
12.12.21
4.76%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Immutep LTD ADR
Start price
Target price
Perf. (%)
€5.85
10.12.20
10.12.20
€5.00
-20.34%
10.12.20
10.12.20
Could be very worthwhile Investment >20% year
Bio Path Holdings
Start price
Target price
Perf. (%)
€2.80
04.12.20
04.12.20
-
04.12.21
04.12.21
-81.43%
05.12.21
05.12.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Ever-Glory International
Start price
Target price
Perf. (%)
€6.05
03.12.20
03.12.20
-
-55.70%
10.12.20
10.12.20
Risky Investment
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.12
01.12.20
01.12.20
€20.00
01.12.21
01.12.21
5.26%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
TOP Ships Inc.
Start price
Target price
Perf. (%)
€19.60
30.11.20
30.11.20
€40.00
6.12%
14.12.20
14.12.20
Could be very worthwhile Investment >20% year
HelloFresh SE
Start price
Target price
Perf. (%)
€49.62
29.11.20
29.11.20
€108.00
29.11.21
29.11.21
87.51%
30.11.21
30.11.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bad rating
Baidu Inc. A ADR
Start price
Target price
Perf. (%)
€116.80
28.11.20
28.11.20
-
28.11.21
28.11.21
115.33%
19.02.21
19.02.21
ROE higher than 15% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Small challenges to pay loans and raise capital
Baidu Inc. A ADR
Start price
Target price
Perf. (%)
€116.80
28.11.20
28.11.20
-
28.11.21
28.11.21
115.33%
19.02.21
19.02.21
ROE higher than 15% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Small challenges to pay loans and raise capital
Fuel Techs Inc.
Start price
Target price
Perf. (%)
€4.88
24.11.20
24.11.20
-
24.11.21
24.11.21
-68.65%
25.11.21
25.11.21
Probably not worthwhile Investment
Aemetis Inc.
Start price
Target price
Perf. (%)
€1.74
23.11.20
23.11.20
€15.00
23.11.21
23.11.21
796.55%
24.11.21
24.11.21
Could be very worthwhile Investment >20% year
Kazia Therapeutics ADR
Start price
Target price
Perf. (%)
€10.50
19.11.20
19.11.20
-
19.11.21
19.11.21
-28.57%
19.11.21
19.11.21
Risky Investment
Socket Mobile Inc.
Start price
Target price
Perf. (%)
€2.40
19.11.20
19.11.20
-
19.11.21
19.11.21
103.58%
20.11.21
20.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Dixie Group Inc.
Start price
Target price
Perf. (%)
€1.61
19.11.20
19.11.20
-
19.11.21
19.11.21
222.98%
20.11.21
20.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Aptevo Therapeutics Inc.
Start price
Target price
Perf. (%)
€42.00
19.11.20
19.11.20
€50.00
19.11.21
19.11.21
-67.07%
07.11.21
07.11.21
Could be very worthwhile Investment >20% year
Socket Mobile Inc.
Start price
Target price
Perf. (%)
€2.80
18.11.20
18.11.20
€4.00
18.11.21
18.11.21
-25.00%
28.11.20
28.11.20
Could be worthwhile Investment >10% per year
Fair valuation
Bad rating
Few uniques